By clicking “Accept All Cookies”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts. View our Privacy Policy for more information.
The formulation development for a poorly water soluble antipsychotic drug aripiprazole is presented using µFluxTM apparatus, a technique, which, besides measuring dissolution follows the flux at the same time enabling to achieve better in vitro-in vivo correlation.